|
|
|
Volumn 73, Issue 8, 2015, Pages 1330-1335
|
|
Cancer therapy by PARP inhibitors
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2-(4-(PIPERIDIN-3-YL)PHENYL)-2H-INDAZOLE-7-CARBOXAMIDE;
ANTINEOPLASTIC AGENT;
BENZIMIDAZOLE DERIVATIVE;
BRCA1 PROTEIN;
BRCA1 PROTEIN, HUMAN;
BRCA2 PROTEIN;
BRCA2 PROTEIN, HUMAN;
ENZYME INHIBITOR;
INDAZOLE DERIVATIVE;
INDOLE DERIVATIVE;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;
OLAPARIB;
PHTHALAZINE DERIVATIVE;
PIPERAZINE DERIVATIVE;
PIPERIDINE DERIVATIVE;
RUCAPARIB;
SINGLE STRANDED DNA;
TALAZOPARIB;
VELIPARIB;
ANTAGONISTS AND INHIBITORS;
DNA REPLICATION;
DOUBLE STRANDED DNA BREAK;
DRUG EFFECTS;
GENETICS;
HUMAN;
MOLECULARLY TARGETED THERAPY;
MUTATION;
NEOPLASMS;
PHYSIOLOGY;
RECOMBINATION REPAIR;
ANTINEOPLASTIC AGENTS;
BENZIMIDAZOLES;
BRCA1 PROTEIN;
BRCA2 PROTEIN;
DNA BREAKS, DOUBLE-STRANDED;
DNA REPLICATION;
DNA, SINGLE-STRANDED;
ENZYME INHIBITORS;
HUMANS;
INDAZOLES;
INDOLES;
MOLECULAR TARGETED THERAPY;
MUTATION;
NEOPLASMS;
PHTHALAZINES;
PIPERAZINES;
PIPERIDINES;
POLY(ADP-RIBOSE) POLYMERASES;
RECOMBINATIONAL DNA REPAIR;
|
|
EID: 84941737120
PISSN: 00471852
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (5)
|
|
References (0)
|